Two fixed-term offers, two total charges
The introductory page, checked September 27, 2026, listed $210 for two months of compounded semaglutide and $300 for two months of compounded tirzepatide. These work out to $105 and $150 per month respectively. The page describes medical oversight and delivery as included and says the introductory program has no recurring charges.
That structure may appeal to someone who wants to avoid an automatic refill during an initial program. It still requires a clinical assessment, and the site’s treatment menu is not a dosing recommendation from this review. Ask which offer the clinician considers appropriate and confirm the total before submitting payment.
The continuing rate is a different number
Both the introductory explanation and the cost page identify standard refills at $285 monthly for semaglutide or $360 for tirzepatide. The cost page describes a flat rate across doses, without a separate membership or subscription charge. The introductory page says patients decide whether and when to reorder.
For a simple four-month budget, a $210 introduction plus two $285 refills equals $780. The corresponding tirzepatide calculation is $300 plus two $360 refills, or $1,020. These examples assume the same listed offers remain available and treatment continues; they are arithmetic comparisons, not a quote or a recommendation to purchase four months of medication.
Match the bundle to the care you need
The cost breakdown lists medication, telehealth review, shipping and ongoing support within its stated rate. A bundled bill can be easier to compare when those components are spelled out. Ask whether additional testing, a replacement shipment or a separate appointment could create charges beyond that listed package.
The website’s descriptions do not tell us which professional would handle a particular patient or how quickly a clinical message receives a reply. Identify the treating clinician and dispensing pharmacy before relying on the bundle. Free shipping and clinician access are commercial service claims, not evidence that this review tested delivery or follow-up.
Use the terms for the selected service
IVUSE+’s general terms cover recurring subscriptions for some products and services, while the GLP-1 introduction explicitly says it does not auto-renew. The broader terms also state that customized prescription orders cannot be refunded once shipped and that dispensed prescription products cannot be returned.
Do not assume every service on a mixed wellness site uses the same billing model. Save the specific offer and ask when the order becomes noncancelable. If there is a medical decision not to proceed, ask which review, service or medication charges are affected. The public general policy does not settle every possible order-stage question.
What makes the offer worth comparing
The useful combination is a clearly identified introductory period, a published continuing price and an option to reorder rather than automatically renew the starter program. The largest budgeting mistake would be extending the $105 or $150 monthly equivalent across a year without accounting for the refill rate.
Compounded preparations are not FDA-approved. We do not treat the site’s outcome percentages or comparisons with branded retail prices as proof of equivalent treatment. This review examines public costs and service terms. Our PreventiveMD review looks at longer prepaid blocks, while the Rx Outreach review covers a different pharmacy-access model.
Common questions
Does the two-month introduction automatically renew?
The introductory page says it is a fixed-term program with no recurring charge; patients decide whether to order standard-price refills.
Can I use the introductory monthly equivalent as the ongoing cost?
No. The published standard refill rates are $285 for semaglutide and $360 for tirzepatide. Verify the selected plan and current terms.
Sources and fact-checking
Sources checked 2026-09-27. Company pages document their own published terms; government and research sources provide context. This is a review of published information, not a hands-on service test or a clinical evaluation. Prices and availability can change.